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The patient was a 56-year-old female. She was referred to our department for further examination of
right hydronephrosis in 2010. Computed tomography (CT) showed right hydronephrosis, and retrograde
pyelography (RP) revealed stenosis of the right lower ureter. Urine cytology was negative. Transurethral
biopsy of the right ureter was performed using ureteroscopic cup forceps and the histopathlogical diagnosis
was ureteral amyloidosis. A whole-body search was performed, including rectal biopsy, but no evidence of
amyloidosis was obtained. She was diagnosed with localized amyloidosis of the right ureter. A ureteral
stent was indwelled and the patient was given occulusive dressing technique (ODT) therapy using dimethyl
sulfoxide (DMSO) for 1 year. After ODT therapy, right hydronephrosis improved. After a 2-year follow-
up, it worsened. ODT therapy was restarted and continued for 2 years. She consulted our department
because of fever and right lumbago in April 2017 after a 4-month interruption of ODT therapy. CT
revealed progression of the right hydronephrosis. A ureteral stent was indwelled and ODT therapy was
restarted. The right hydronephrosis improved after 1 year. ODT therapy using DMSO was effective for
localized ureteral amyloidosis, but periodic follow-up was necessary and ODT therapy was also effective
when it recurred after the interruption of treatment.
(Hinyokika Kiyo 65 : 117-121, 2019 DOI : 10.14989/ActaUrolJap_65_4_117)






DMSO）の occulusive dressing technique（以下 ODT）
療法を行い， 8年間の長期 follow-up を行ったので報
告する．
症 例
患 者 : 56歳，女性
既往歴 : 特記すべきことなし
主 訴 : 右腰痛と発熱
現病歴 : 2010年に右腰痛にて近医を受診し，腹部エ
コーにて右水腎症を認めたため当科紹介受診した．













除術と自己で施行可能な DMSO の ODT 療法の説明
をしたところ仕事で休暇が取れないため後者を希望し
た．使用した薬剤は DMSO 250 ml に注射用水を 250









Fig. 1. a) CT revealed right hydronephrosis. b) RP revealed stenosis of the right lower ureter. The arrow
shows the right ureteral stenosis. c) Histopathological findings revealed ureteral amyloidosis (H-E
staining, objective lens,×20). d) Ureteral deposits were positive on direct fast scarlet (DFS) staining (DFS
staining, polaroid lens,×20).
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Fig. 2. Drip infusion pyelography (DIP) revealed








2）．その後 2年間は 3カ月おきに腎エコーと年 2回の






現 症 : 右 CVA に圧痛を認めた．
血圧 120/80 mmHg，脈拍84/分，体温 38.2°C
血液一般 : RBC 406万 / μ l，Hb 12. 4 g/dl，WBC





Fig. 3. CT revealed right hydronephrosis after a 4-
month interruption of ODT therapy. a)





Fig. 4. a) DIP revealed improvement of the right
hydronephrosis. b) A renogram revealed
decreasing right renal function.
10,400/μl，Plt 17.7万/μl
血液生化学検査 : 肝機能，電解質正常．
BUN 16. 2 mg/dl，Cre 0. 7 mg/dl，eGFR 66. 7 ml/




尿沈渣 RBC 50∼99/hpf，WBC 50∼99/hpf
尿培養 Enterococcus faecalis








希望したため 2週間後に DMSO の ODT 療法を再開
することにした．尿管ステントは 2カ月ごとに交換し
ていたが右水腎症は改善傾向にあり 1年後に抜去し
た．尿管ステント抜去後の DIP を示す（Fig. 4a）．レ
ノグラムでは総 glomerular filtration rate（GFR）は
102. 8 ml/min（正常 90.0 以上）で左腎の GFR は
62.9 ml/min，右腎の GFR は 39.9 ml/min で右腎機能
は左腎に比べ低下していた（Fig. 4b）．その後も ODT
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Fig. 5. Clinical course of the patient.




主 訴 血尿36例，側腹部痛20例，水腎症 8例，腰背部痛
6例，その他 9例
患 側 左45例，右30例，両側 4例
部 位
下部尿管39例，中部尿管18例，尿管膀胱移行部 9





4例，尿管カテーテル留置 2例，DMSO の ODT
療法 3例，DMSO の内服 2例，尿管皮膚瘻 1例，























次に尿管部分切除が28例であり，DMSO の ODT 療
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